131 related articles for article (PubMed ID: 15522400)
1. Studies on activities, cell up take and DNA binding of four multinuclear complexes of the form: [[trans-PtCl(NH(3))(2)](2)mu-[trans-Pd(NH(3))(2)-(H(2)N(CH(2))(n)NH(2))(2)]]Cl(4) where n=4-7.
Daghriri H; Huq F; Beale P
J Inorg Biochem; 2004 Nov; 98(11):1722-33. PubMed ID: 15522400
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterisation, activities, cell uptake and DNA binding of [[trans-PtCl(NH3)2] [mu-(H2N(CH2)6NH2)] [trans-PdCl(NH3)2](NO3)Cl.
Huq F; Daghriri H; Yu JQ; Tayyem H; Beale P; Zhang M
Eur J Med Chem; 2004 Nov; 39(11):947-58. PubMed ID: 15501544
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, activities, cell uptake and DNA binding of trinuclear complex: [{trans-PtCl(NH(3))}(2)mu-{trans-Pt(NH(3))(2-hydroxypyridine)-(H(2)N(CH(2))(6)NH(2))(2)]Cl(4).
Cheng H; Huq F; Beale P; Fisher K
Eur J Med Chem; 2005 Aug; 40(8):772-81. PubMed ID: 16122580
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterisation, activities, cell uptake and DNA binding of a trinuclear complex: [[trans-PtCl(NH3)]2mu-[trans-Pd(NH3)(2-hydroxypyridine)-(H2)N(CH2)6NH2)2]Cl4.
Cheng H; Huq F; Beale P; Fisher K
Eur J Med Chem; 2006 Jul; 41(7):896-903. PubMed ID: 16730394
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH3)2}2mu-{trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in ovarian cancer cell lines.
Tayyem H; Huq F; Yu JQ; Beale P; Fisher K
ChemMedChem; 2008 Jan; 3(1):145-51. PubMed ID: 17963210
[TBL] [Abstract][Full Text] [Related]
6. Studies on activities, cell uptake and DNA binding of four trans-planaramineplatinum(II) complexes of the form: trans-PtL(NH3)Cl2, where L=2-hydroxypyridine, imidazole, 3-hydroxypyridine and imidazo(1,2-alpha)pyridine.
Huq F; Yu JQ; Daghriri H; Beale P
J Inorg Biochem; 2004 Aug; 98(8):1261-70. PubMed ID: 15271501
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumour activity of a new trinuclear platinum compound [{cis-PtCl(NH3)2μ {trans-Pt(3-hydroxypyridine)2H2N(CH2)5NH2)2}] Cl4 in human ovarian cancer cells.
Hamad SA; Beale P; Yu JQ; Huq F
Anticancer Res; 2014 Apr; 34(4):1923-9. PubMed ID: 24692727
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models.
Deqnah N; Yu JQ; Beale P; Fisher K; Huq F
Anticancer Res; 2012 Jan; 32(1):135-40. PubMed ID: 22213298
[TBL] [Abstract][Full Text] [Related]
9. Studies on combinations of platinum with paclitaxel and colchicine in ovarian cancer cell lines.
Yunos NM; Beale P; Yu JQ; Strain D; Huq F
Anticancer Res; 2010 Oct; 30(10):4025-37. PubMed ID: 21036717
[TBL] [Abstract][Full Text] [Related]
10. Studies on synthesis, activity and binding with DNA of a new trinuclear platinum compound [{trans-PtCl(NH3)2}2{trans-Pt(thiazole)2}{H2N(CH2)(6NH2}2]Cl3(NO3).
Al-Shuneigat J; Qing Y; Beale P; Fisher K; Huq F
Med Chem; 2011 Jan; 7(1):1-8. PubMed ID: 21235513
[TBL] [Abstract][Full Text] [Related]
11. Effect of the geometry of the central coordination sphere in antitumor trinuclear platinum complexes on DNA binding.
Kasparkova J; Vrana O; Farrell N; Brabec V
J Inorg Biochem; 2004 Oct; 98(10):1560-9. PubMed ID: 15458817
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, activity and binding with DNA of [{trans-PtCl(NH(3))(2)}(2)micro-{trans-Pd(4-hydroxypyridine) (2) (H(2)N(CH(2))(6)NH(2))(2)]Cl(4) (TH8).
Huq F; Tayyem H; Yu JQ; Beale P; Fisher K
Med Chem; 2009 Jul; 5(4):372-81. PubMed ID: 19689395
[TBL] [Abstract][Full Text] [Related]
13. Trifunctional dinuclear platinum complexes as DNA-protein cross-linking agents.
Kloster M; Kostrhunova H; Zaludova R; Malina J; Kasparkova J; Brabec V; Farrell N
Biochemistry; 2004 Jun; 43(24):7776-86. PubMed ID: 15196020
[TBL] [Abstract][Full Text] [Related]
14. Studies on the synthesis and activity of three tripalladium complexes containing planaramine ligands.
Farhad M; Yu JQ; Beale P; Fisher K; Huq F
ChemMedChem; 2009 Nov; 4(11):1841-9. PubMed ID: 19746359
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and cytotoxicity of three trans-palladium complexes containing planaramine ligands in human ovarian tumor models.
Mazumder ME; Beale P; Chan C; Yu JQ; Huq F
ChemMedChem; 2012 Oct; 7(10):1840-6. PubMed ID: 22899663
[TBL] [Abstract][Full Text] [Related]
16. Studies of interaction of trichloro{eta2-cis-N,N-dimethyl-1-[6-(N',N'-dimethyl-ammoniummethyl)-cyclohex-3-ene-1-yl]-methylammonium}platinum(II) chloride with DNA: Effects on secondary and tertiary structures of DNA. Cytotoxic assays on human ovarian cancer cell lines, resistant and non-resistant to cisplatin.
Gay M; Montaña AM; Moreno V; Prieto MJ; Pérez JM; Alonso C
Bioorg Med Chem; 2006 Mar; 14(5):1565-72. PubMed ID: 16256352
[TBL] [Abstract][Full Text] [Related]
17. Synergism from combination of cisplatin and a trans-platinum compound in ovarian cancer cell lines.
Alshehri A; Beale P; Yu JQ; Huq F
Anticancer Res; 2010 Nov; 30(11):4547-53. PubMed ID: 21115904
[TBL] [Abstract][Full Text] [Related]
18. Studies on the activity of three palladium(II) compounds of the form: trans-PdL2Cl2 where L=2-hydroxypyridine, 3-hydroxypyridine, and 4-hydroxypyridine.
Huq F; Tayyem H; Beale P; Yu JQ
J Inorg Biochem; 2007 Jan; 101(1):30-5. PubMed ID: 16997377
[TBL] [Abstract][Full Text] [Related]
19. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization and binding with DNA of four planaramineplatinum(II) complexes of the forms: trans-PtL2Cl2 and [PtL3Cl]Cl, where L = 3-hydroxypyridine, 4-hydroxypyridine and imidazo(1,2-alpha)pyridine.
Chowdhury MA; Huq F; Abdullah A; Beale P; Fisher K
J Inorg Biochem; 2005 May; 99(5):1098-112. PubMed ID: 15833333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
